Summary Safety Review - Hydrocodone-containing products - Assessing the Risk of Serious Breathing Problems (respiratory depression) in Children and Adolescents

Summary Safety Review - Hydrocodone-containing products - Assessing the Risk of Serious Breathing Problems (respiratory depression) in Children and Adolescents It is known that hydrocodone can slow breathing when too much is taken. The labelling for these drugs already warns of this risk and it applies to all ages, including children. Health Canada’s safety review activities on hydrocodone further studied the risk of serious breathing problems in children and adolescents and stems from review work with codeine (another opioid drug) to determine if more safety measures were needed. 2024-05-09 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetySummary Safety ReviewHydrocodone-containing productsassessingriskslow breathingSerious-Breathing-Problemsrespiratory depression Summary Safety Review - Hydrocodone-containing products - Assessing the Risk of Serious Breathing Problems (respiratory depression) in Children and AdolescentsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/examens-innocuite/resume-examen-innocuite-produits-contenant-hydrocodone-evaluation-risque.html

It is known that hydrocodone can slow breathing when too much is taken. The labelling for these drugs already warns of this risk and it applies to all ages, including children. Health Canada’s safety review activities on hydrocodone further studied the risk of serious breathing problems in children and adolescents and stems from review work with codeine (another opioid drug) to determine if more safety measures were needed.

Data and Resources

Similar records